Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gritstone bio Inc GRTSQ

Healthcare Biotechnology
Gritstone bio, Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. It has developed two vectors that it deploys with the aim of eliciting the desired immune response: self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage... see more

Recent & Breaking News (PINL:GRTSQ)

Gritstone bio to Participate in Upcoming Investor Conferences

GlobeNewswire November 20, 2023

Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

GlobeNewswire November 8, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 7, 2023

Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio's Next Generation COVID-19 Vaccine

GlobeNewswire October 11, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 10, 2023

Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023

GlobeNewswire October 4, 2023

Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million

GlobeNewswire September 27, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 13, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

GlobeNewswire September 5, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 16, 2023

Gritstone bio and Genevant Sciences Announce Option and License Agreement

GlobeNewswire August 15, 2023

Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

GlobeNewswire August 9, 2023

Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project

GlobeNewswire August 7, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 17, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire June 13, 2023

Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications

GlobeNewswire June 8, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

GlobeNewswire June 1, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire May 24, 2023

Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates

GlobeNewswire May 11, 2023

Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023

GlobeNewswire May 3, 2023